NDC Pharmacologic Class N0000000194 Somatostatin Receptor Agonists [MoA]

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Product Type
0078-0180	Sandostatin	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0181	Sandostatin	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0182	Sandostatin	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0633	Signifor	Pasireotide	Injection	Subcutaneous	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0634	Signifor	Pasireotide	Injection	Subcutaneous	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0635	Signifor	Pasireotide	Injection	Subcutaneous	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0641-6174	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Hikma Pharmaceuticals Usa Inc.	Human Prescription Drug
0641-6175	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Hikma Pharmaceuticals Usa Inc.	Human Prescription Drug
0641-6176	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Hikma Pharmaceuticals Usa Inc.	Human Prescription Drug
0641-6177	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Hikma Pharmaceuticals Usa Inc.	Human Prescription Drug
0641-6178	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Hikma Pharmaceuticals Usa Inc.	Human Prescription Drug
0703-3301	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Teva Parenteral Medicines, Inc.	Human Prescription Drug
0703-3311	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Teva Parenteral Medicines, Inc.	Human Prescription Drug
0703-3321	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Teva Parenteral Medicines, Inc.	Human Prescription Drug
0703-3333	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Teva Parenteral Medicines, Inc.	Human Prescription Drug
0703-3343	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Teva Parenteral Medicines, Inc.	Human Prescription Drug
15054-1060	Somatuline Depot	Lanreotide Acetate	Injection	Subcutaneous	Ipsen Biopharmaceuticals, Inc.	Human Prescription Drug
15054-1090	Somatuline Depot	Lanreotide Acetate	Injection	Subcutaneous	Ipsen Biopharmaceuticals, Inc.	Human Prescription Drug
15054-1120	Somatuline Depot	Lanreotide Acetate	Injection	Subcutaneous	Ipsen Biopharmaceuticals, Inc.	Human Prescription Drug
25021-451	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Sagent Pharmaceuticals	Human Prescription Drug
25021-452	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Sagent Pharmaceuticals	Human Prescription Drug
25021-453	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Sagent Pharmaceuticals	Human Prescription Drug
25021-454	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Sagent Pharmaceuticals	Human Prescription Drug
25021-455	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Sagent Pharmaceuticals	Human Prescription Drug
55292-131	Signifor	Pasireotide	Injection	Subcutaneous	Recordati Rare Diseases, Inc.	Human Prescription Drug
55292-132	Signifor	Pasireotide	Injection	Subcutaneous	Recordati Rare Diseases, Inc.	Human Prescription Drug
55292-133	Signifor	Pasireotide	Injection	Subcutaneous	Recordati Rare Diseases, Inc.	Human Prescription Drug
62756-452	Bynfezia Pen	Octreotide Acetate	Injection	Subcutaneous	Sun Pharmaceutical Industries, Inc.	Human Prescription Drug
63323-365	Octreotide	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Fresenius Kabi Usa, Llc	Human Prescription Drug
63323-376	Octreotide	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Fresenius Kabi Usa, Llc	Human Prescription Drug
63323-377	Octreotide	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Fresenius Kabi Usa, Llc	Human Prescription Drug
63323-378	Octreotide	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Fresenius Kabi Usa, Llc	Human Prescription Drug
63323-379	Octreotide	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Fresenius Kabi Usa, Llc	Human Prescription Drug
67457-239	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Mylan Institutional Llc	Human Prescription Drug
67457-245	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Mylan Institutional Llc	Human Prescription Drug
67457-246	Octreotide Acetate	Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Mylan Institutional Llc	Human Prescription Drug
69880-120	Mycapssa	Octreotide	Capsule, Delayed Release	Oral	Chiasma Inc.	Human Prescription Drug

There are 37 NDC products with the pharmacologic class Somatostatin Receptor Agonists [MoA].